The role of the comparison group in epidemiology and general limitations

Addiction

Volumn 108, Issue 12, 2013, Pages 2058-2059

  Rehm, Jurgen ^a,b,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

CHRONIC DISEASE; DRINKING BEHAVIOR; HUMAN; PATHOPHYSIOLOGY; NOTE;

ALCOHOL DRINKING; CHRONIC DISEASE; ETHANOL; HUMANS;

EID: 84887513303     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12189     Document Type: Article

References (16)

1. Fekjaer H. O. Alcohol-a universal preventive agent? A critical analysis. Addiction 2013; 108: 2051-2057.
2. Shaper A., Wannamethee G., Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988; 2: 1267-1273.
3. Bondy S., Rehm J. The interplay of drinking patterns and other determinants of health. Drug Alcohol Rev 1998; 17: 399-412.
4. Rehm J., Irving H., Ye Y., Kerr W. C., Bond J., Greenfield T. K. Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol 2008; 168: 866-871.
5. World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2011.
6. Shield K., Rylett M., Gmel G., Gmel G., Kehoe-Chan T., Rehm J. Global alcohol exposure estimates by country, territory and region for 2005-a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 2013; 108: 912-922.
7. Rehm J., Klotsche J., Patra J. Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 2007; 16: 66-76.
8. Sudman S., Bradburn N., Schwarz N. Thinking about Answers: The Application of Cognitive Processes to Survey Methodology. New York: Wiley; 2006.
9. Rogers R. G., Krueger P. M., Miech R., Lawrence E. M. Lifetime Abstainers and Mortality Risk in the United States. Boulder, CO: University of Colorado Boulder, Institute of Behavioral Sciences; 2013.
10. Roerecke M., Rehm J. What is best evidence in epidemiology? A reply to Stockwell. Addiction 2013; 108: 427-428.
11. International Agency for Research on Cancer. Alcoholic beverage consumption and ethyl carbamate (urethane). IARC Monograph 96 on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: International Agency for Research on Cancer (IARC); 2010.
12. Roerecke M., Rehm J. Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep 2012; 14: 556-562.
13. Lim S. S., Vos T., Flaxman A. D., Danaei G., Shibuya K., Adair-Rohani H. etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
14. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 2009; 373: 2223-2233.
15. Rehm J., Shield K. D., Rehm M. X., Gmel G., Frick U. Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol 2013; 23: 89-97.
16. World Health Organization. Global Strategy to Reduce the Harmful Use of Alcohol. Geneva, Switzerland: World Health Organization; 2010.